会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 31. 发明授权
    • 2,4-Disubstituted-5-oxo-5H-dibenzo[a,d]cycloheptenes
    • 2,4-二取代-5-氧代-5H-二苯并{8α,d {9环庚烯
    • US4172949A
    • 1979-10-30
    • US920047
    • 1978-06-28
    • James P. DunnPeter H. NelsonKarl G. Untch
    • James P. DunnPeter H. NelsonKarl G. Untch
    • C07C51/36C07C59/90C07C65/28C07C65/40C07C65/14C07C69/76
    • C07C65/40C07C51/36C07C59/90C07C65/28Y10S514/825Y10S514/916
    • Compounds of the formula ##STR1## wherein R is hydrogen or methyl; R.sup.1 is hydrogen, C.sub.1 to C.sub.8 linear or branched alkyl or C.sub.1 to C.sub.8 linear or branched alkanoyl; X is oxygen or sulfur; R.sup.2 is selected from the group hydrogen, C.sub.1 to C.sub.18 linear or branched alkyl and the radicals --(CH.sub.2).sub.n --NR.sup.3 R.sup.4, --CH.sub.2 --CH(OH)--CH.sub.2 --OH or a ketal thereof formed from the aldehyde or ketone R.sup.5 R.sup.6 CO, wherein R.sup.3 and R.sup.4 are each independently C.sub.1 to C.sub.6 linear or branched alkyl or R.sup.3 and R.sup.4 taken together with the nitrogen atom of the first radical are attached to form a 5- or 6-membered heterocyclic ring, R.sup.5 and R.sup.6 are each independently hydrogen, C.sub.1 to C.sub.6 linear or branched alkyl, phenyl or benzyl or R.sup.5 and R.sup.6 taken together represent an alkylene bridge of from 4 to 6 carbon atoms; n is an integer of from 2 to 4; and the dotted line represents an optional double bond; and the pharmaceutically acceptable salts thereof. The compounds have anti-inflammatory, analgesic and anti-pyretic activities and, accordingly, are useful in the treatment of inflammation, pain and/or pyrexia.
    • 式(I)的化合物,其中R是氢或甲基; R1是氢,C1至C8直链或支链烷基或C1至C8直链或支链烷酰基; X是氧或硫; R2选自氢,C1至C18直链或支链烷基和由醛或酮R5R6CO形成的基团 - (CH2)n-NR3R4,-CH2-CH(OH)-CH2-OH或其缩酮,其中 R 3和R 4各自独立地为C 1至C 6直链或支链烷基或与第一基团的氮原子一起的R 3和R 4连接以形成5-或6-元杂环,R 5和R 6各自独立地为氢,C 1 C 6直链或支链烷基,苯基或苄基或R 5和R 6一起表示4至6个碳原子的亚烷基桥; n为2〜4的整数, 虚线表示任选的双键; 及其药学上可接受的盐。 这些化合物具有抗炎,止痛和抗热解活性,因此可用于治疗炎症,疼痛和/或发热。
    • 37. 发明授权
    • Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
    • 霉酚酸衍生物治疗类风湿关节炎
    • US4725622A
    • 1988-02-16
    • US821633
    • 1986-01-23
    • Peter H. NelsonAnthony C. AllisonElsie M. EuguiJoseph M. Muchowski
    • Peter H. NelsonAnthony C. AllisonElsie M. EuguiJoseph M. Muchowski
    • C07D307/88A61K31/44
    • C07D307/88
    • A method of treating rheumatoid arthritis which method comprises administering to a mammal in need of such treatment a therapeutically effective amount of a compound of the formula: ##STR1## and the pharmaceutically acceptable salts thereof, wherein:A is oxygen or sulfur;R.sup.1 is selected from the group consisting of H, ##STR2## in which Y is oxygen or sulfur:R.sup.2 is alkyl, haloalkyl or --NR.sup.4 R.sup.5, where R.sup.4 and R.sup.5 are independently H, alkyl, haloalkyl, cycloalkyl, phenyl optionally monosubstituted with halogen, hydroxy, carboxy, chlorocarbonyl, sulfonylamino, nitro, cyano, phenyl, alkyl, acyl, alkoxycarbonyl, acylamino, dialkylamino or dialkylaminoethoxycarbonyl, phenyl optionally disubstituted with hydroxy, carboxy, nitro or alkyl, or benzyl optionally substituted with dialkylamino;n is an integer from 0-6;R.sup.3 is H alkyl or a pharmaceutically acceptable cation;Q and R are independently H or --CO.sub.2 R.sup.3 ; andZ is selected from the group consisting of ##STR3## in which X is oxygen or sulfur,R.sup.7 is H, alkyl, alkenyl, cycloalkyl, optionally substituted phenyl, optionally substituted benzyl or a pharmaceutically acceptable cation; andR.sup.8 and R.sup.9 are independently H, alkyl or cycloalkyl, or R.sup.8 and R.sup.9 taken together are --(CH.sub.2).sub.4 --, --(CH.sub.2).sub.5 -- or --(CH.sub.2).sub.2 O(CH.sub.2).sub.2 --;with the proviso that R.sup.1 and R.sup.7 cannot both be H if X and A are oxygen.
    • 治疗类风湿性关节炎的方法,该方法包括向需要这种治疗的哺乳动物施用治疗有效量的下式化合物及其药学上可接受的盐,其中:A为氧或硫; 其中Y是氧或硫:R 2是烷基,卤代烷基或-NR 4 R 5,其中R 4和R 5独立地是H,烷基,卤代烷基,环烷基,任选被卤素单取代的苯基, 羟基,羧基,氯代羰基,磺酰基氨基,硝基,氰基,苯基,烷基,酰基,烷氧基羰基,酰氨基,二烷基氨基或二烷基氨基乙氧基羰基,任选被羟基,羧基,硝基或烷基二取代的苯基或任选被二烷基氨基取代的苄基; n是0-6的整数; R3是H烷基或药学上可接受的阳离子; Q和R独立地是H或-CO 2 R 3; Z选自CH 2 OH,CHO,CN,1H-四唑基,其中X是氧或硫,R 7是H,烷基,烯基,环烷基,任选取代的苯基,任选取代的苄基或药学上 可接受的阳离子 并且R 8和R 9独立地为H,烷基或环烷基,或者R 8和R 9一起为 - (CH 2)4 - , - (CH 2)5 - 或 - (CH 2)2 O(CH 2)2 - 条件是如果X和A是氧,则R1和R7不能都是H。
    • 38. 发明授权
    • Benzthiazine analogs as antiinflammatory agents
    • 苯并噻嗪类似物作为抗炎剂
    • US4512990A
    • 1985-04-23
    • US349738
    • 1982-02-18
    • Peter H. NelsonHoward J. RingoldStefan H. UngerThomas R. Thieme
    • Peter H. NelsonHoward J. RingoldStefan H. UngerThomas R. Thieme
    • C07D215/06C07D215/08C07D279/16A61K31/54
    • C07D279/16C07D215/06C07D215/08
    • Compounds of the formula: ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein: Z is S;Y is halo, alkoxy, alkyl, or dialkylamino;a is 0, 1 or 2;b is an integer from 2-12 with the proviso that if b is 2 or 3, a cannot be 0, and with the further proviso that if X is OH, b cannot be 2-5 and with the further proviso that if X is --NH.sub.2, b cannot be 2-5; andX is selected from the group consisting of: --OH, OR.sup.1, --NH.sub.2, --NHR.sup.1, NR1/2, ##STR2## and --NHCONHR.sup.2 in which each R.sup.1 is independently alkyl or cycloalkyl or, in --NR1/2, both R.sup.1 s together are alkylene or form a piperazine ring optionally substituted at the ring N by alkyl or --CH.sub.2 CH.sub.2 OH; andR.sup.2 is alkyl, cycloalkyl, or optionally substituted phenyl;have antiinflammatory properties and are useful in the treatment of conditions characterized by inflammation and swelling.
    • 下式的化合物:其中:Z是S;和其药学上可接受的酸加成盐。 Y是卤素,烷氧基,烷基或二烷基氨基; a是0,1或2; b为2-12的整数,条件是如果b为2或3,则a不能为0,另外条件是如果X为OH,则b不能为2-5,进一步的条件是,如果X为 -NH2,b不能为2-5; 并且X选自:-OH,OR 1,-NH 2,-NHR 1,NR 1/2,< IMAGE>和-NHCONHR 2,其中每个R 1独立地为烷基或环烷基,或在-NR 1/2中, 一起是亚烷基或形成在环N任选被烷基或-CH 2 CH 2 OH取代的哌嗪环; 并且R 2是烷基,环烷基或任选取代的苯基; 具有抗炎性质,可用于治疗以炎症和肿胀为特征的病症。